BOSTON, May 19, 2011 /PRNewswire/ -- Perceptive Informatics, the industry's leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced results of a global survey conducted during its webinar entitled "Critical Tasks of Site Monitors: Using a CTMS to Improve Efficiency." Perceptive polled biopharmaceutical industry professionals across a broad range of clinical, data management and IT functions about the value of providing Clinical Research Associates (CRAs) with access to a Clinical Trial Management System (CTMS) to assist in site monitoring and management activities during clinical trials.
The survey results revealed that 89% of respondents provide CRAs with access to either a CTMS or other monitoring tool. The majority of these respondents combine other monitoring tools with a CTMS to achieve greater site monitoring and management efficiencies. A CTMS helps CRAs to view the status of a clinical trial, access patient data, and identify outstanding issues, as well as to make informed decisions about requirements for site visits. The remaining respondents (11%) provide no access to these types of systems.
"As site management is a key part of the CRA role, providing CRAs with access to the cross-study and cross-site data available within a CTMS is vital. There is growing recognition across the industry that when CRAs use sophisticated eClinical technologies they are more efficient in site monitoring and management activities," said Liz Love, Product Manager of CTMS, Perceptive Informatics. "At Perceptive, we are focused on enabling more effective centralized and field-based monitoring through our CTMS to support an increasingly mobile and globalized CRA workforce."